Tumor necrosis factor-alpha (TNF-alpha) is a pro-inflammatory cytokine that has pleiotropic effects on a wide variety of tissues. The role of TNF-alpha in insulin-dependent diabetes mellitus (IDDM) has been a controversial issue. Previous studies have shown that in vitro, TNF- alpha in combination with other cytokines such as IL-1 is cytotoxic to pancreatic beta cells while administration of TNF-alpha in vivo in adult non-obese diabetic (NOD) mice can prevent diabetes. Recently, it has been shown that TNF-alpha is produced very early during thymic development and that administration of anti-TNF-alpha antibody can block normal thymic development in mice. Interestingly, our most recent study has demonstrated that administration of TNF-alpha in newborn NOD mice, in contrast to the result obtained with adult mice, accelerates disease onset while anti-TNF-alpha treatment inhibits insulitis and completely prevents diabetes. These data indicate that TNF-alpha may play a critical role in lymphocyte development and particularly in the generation of autoimmunity to pancreatic beta cells. Our proposed study will focus on the cellular and molecular mechanisms by which TNF-alpha can effect both the development of immature lymphocytes in the thymus and the function of mature T helper cells and effector cytotoxic lymphocytes. The approaches to be used will include: (1) treatment of newborn NOD mice with TNF-alpha or monoclonal anti-TNF-alpha antibody; (2) examination of TNF-alpha's effect on normal lymphocyte development, and on negative selection; (3) determination of the role of TNF-alpha in the regulation of autoantigen-specific Th1 vs. Th2 responses; (4) measurement of TNF- alpha mediated specific cytotoxic activity specific for pancreatic beta cells; and (4) assessment of the potential effect of TNF-alpha on lymphocyte homing to the pancreatic islets. These studies may lead to a further understanding of the immunopathogenesis of IDDM. A corollary of this work is the possible development of novel approaches for cytokine-based immunotherapy of IDDM.
| Samusik, Nikolay; Good, Zinaida; Spitzer, Matthew H et al. (2016) Automated mapping of phenotype space with single-cell data. Nat Methods 13:493-6 |
| Spitzer, Matthew H; Nolan, Garry P (2016) Mass Cytometry: Single Cells, Many Features. Cell 165:780-91 |
| Frei, Andreas P; Bava, Felice-Alessio; Zunder, Eli R et al. (2016) Highly multiplexed simultaneous detection of RNAs and proteins in single cells. Nat Methods 13:269-75 |
| Angelo, Michael; Bendall, Sean C; Finck, Rachel et al. (2014) Multiplexed ion beam imaging of human breast tumors. Nat Med 20:436-42 |
| Gottlieb, Peter; Utz, Paul J; Robinson, William et al. (2013) Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform. Clin Immunol 149:297-306 |
| O'Gorman, William E; Dooms, Hans; Thorne, Steve H et al. (2009) The initial phase of an immune response functions to activate regulatory T cells. J Immunol 183:332-9 |
| Sachs, Karen; Itani, Solomon; Carlisle, Jennifer et al. (2009) Learning signaling network structures with sparsely distributed data. J Comput Biol 16:201-12 |
| Creusot, Remi J; Yaghoubi, Shahriar S; Chang, Pearl et al. (2009) Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 113:6638-47 |
| Sachs, K; Itani, S; Fitzgerald, J et al. (2009) Learning cyclic signaling pathway structures while minimizing data requirements. Pac Symp Biocomput :63-74 |
| Creusot, Remi J; Yaghoubi, Shahriar S; Kodama, Keiichi et al. (2008) Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin Immunol 127:176-87 |
Showing the most recent 10 out of 27 publications
